Literature DB >> 23983833

Myasthenic crisis.

Linda C Wendell1, Joshua M Levine.   

Abstract

Myasthenic crisis is a complication of myasthenia gravis characterized by worsening of muscle weakness, resulting in respiratory failure that requires intubation and mechanical ventilation. Advances in critical care have improved the mortality rate associated with myasthenic crisis. This article reviews the epidemiology of myasthenic crisis and discusses patient evaluation. Therapeutic options including mechanical ventilation and pharmacological and surgical treatments are also discussed.

Entities:  

Keywords:  autoimmune diseases of the nervous system; myasthenia gravis; neurocritical care clinical specialty; neuromuscular disease clinical specialty

Year:  2011        PMID: 23983833      PMCID: PMC3726100          DOI: 10.1177/1941875210382918

Source DB:  PubMed          Journal:  Neurohospitalist        ISSN: 1941-8744


  58 in total

1.  Masked myasthenia gravis.

Authors:  S J WEISMAN
Journal:  J Am Med Assoc       Date:  1949-11-26

2.  Decade-long experience with surgical therapy of myasthenia gravis: early complications of 324 transsternal thymectomies.

Authors:  J Kas; D Kiss; V Simon; E Svastics; L Major; A Szobor
Journal:  Ann Thorac Surg       Date:  2001-11       Impact factor: 4.330

3.  Aspects of the natural history of myasthenia gravis: crisis and death.

Authors:  M S Cohen; D Younger
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

4.  The role of non-invasive ventilation and factors predicting extubation outcome in myasthenic crisis.

Authors:  Jenn-Yu Wu; Ping-Hung Kuo; Pi-Chuan Fan; Huey-Dong Wu; Fuh-Yuan Shih; Pan-Chyr Yang
Journal:  Neurocrit Care       Date:  2008-09-20       Impact factor: 3.210

5.  Myasthenic Crisis.

Authors:  Jawad F. Kirmani; Abutaher M. Yahia; Adnan I. Qureshi
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

6.  Predictors of extubation failure in myasthenic crisis.

Authors:  Janaka Seneviratne; Jay Mandrekar; Eelco F M Wijdicks; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2008-07

Review 7.  Clinical evaluation and management of myasthenia gravis.

Authors:  John C Keesey
Journal:  Muscle Nerve       Date:  2004-04       Impact factor: 3.217

8.  Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures.

Authors:  Douglas Shemin; Doris Briggs; Melanie Greenan
Journal:  J Clin Apher       Date:  2007       Impact factor: 2.821

Review 9.  Myasthenia gravis: management of myasthenic crisis and perioperative care.

Authors:  Vern C Juel
Journal:  Semin Neurol       Date:  2004-03       Impact factor: 3.420

10.  Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.

Authors:  A Alshekhlee; J D Miles; B Katirji; D C Preston; H J Kaminski
Journal:  Neurology       Date:  2009-05-05       Impact factor: 9.910

View more
  36 in total

1.  Intravenous immunoglobulin for preparing myasthenia gravis patients for thymectomy and other surgical procedures preventing myasthenic crisis.

Authors:  J Gamez
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

2.  Takotsubo cardiomyopathy, or 'broken-heart syndrome', with concomitant myasthenic crisis.

Authors:  Ren Yi Jonas Ho; Zer Rong Beverlyn Chern; William Kristanto
Journal:  Singapore Med J       Date:  2019-05       Impact factor: 1.858

3.  Anesthetic considerations for a patient with myasthenia gravis undergoing deep sedation in an outpatient oral surgery setting.

Authors:  Shamit S Prabhu; Saad A Khan; Alexander L Doudnikoff; Uday N Reebye
Journal:  J Dent Anesth Pain Med       Date:  2019-02-28

Review 4.  Neurologic complications of immune checkpoint inhibitors.

Authors:  Alexandra M Haugh; John C Probasco; Douglas B Johnson
Journal:  Expert Opin Drug Saf       Date:  2020-03-11       Impact factor: 4.250

5.  COVID-19 and Sepsis in an Atypical Case of Mixed Connective Tissue Disorder Presenting With a Myasthenic Crisis.

Authors:  Lav Kumar Shah; Biswas Pant; Nashruva Mony; Sumitanand Mishra; Januka Gaire; Sandesh Sharma
Journal:  Cureus       Date:  2022-09-12

6.  Myasthenia gravis treated in the neurology intensive care unit: a 14-year single-centre experience.

Authors:  Mirjana Zdraljevic; Stojan Peric; Marta Jeremic; Dragana Lavrnic; Ivana Basta; Ljiljana Hajdukovic; Dejana R Jovanovic; Ivana Berisavac
Journal:  Neurol Sci       Date:  2022-09-09       Impact factor: 3.830

7.  A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis.

Authors:  Linda Harris; Sophie Graham; Sharon MacLachlan; Alex Exuzides; Saiju Jacob
Journal:  BMC Neurol       Date:  2022-05-09       Impact factor: 2.903

Review 8.  Giant cell myositis associated with concurrent myasthenia gravis: a case-based review of the literature.

Authors:  Frank A Scangarello; Luisa Angel-Buitrago; Melanie Lang-Orsini; Alexander Geevarghese; Knarik Arkun; Oscar Soto; Mithila Vullaganti; Robert Kalish
Journal:  Clin Rheumatol       Date:  2021-02-25       Impact factor: 2.980

9.  Myasthenic crisis appearing after resection of intracardiac ectopic thymoma with superior vena cava syndrome.

Authors:  Satoshi Takebayashi; Yasuji Yoshikawa; Masato Morita; Ryotaro Nagashima; Yuichi Nakazono; Shinji Miyamoto
Journal:  Surg Case Rep       Date:  2021-06-15

10.  Illness-associated muscle weakness in dystroglycanopathies.

Authors:  Courtney R Carlson; Steven D McGaughey; Jamie M Eskuri; Carrie M Stephan; M Bridget Zimmerman; Katherine D Mathews
Journal:  Neurology       Date:  2017-11-03       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.